The Hunt for the Next 10 Bagger

[TPX]

$MCET On September 26, 2016, the Company’s majority owned subsidiary, MultiCell Immunotherapeutics, Inc. (MCIT), released a presentation
concerning its therapeutic development platform (the “MCIT Presentation”). The MCIT Presentation is furnished as Exhibit 99.1 to this Current
Report on Form 8-K.
The MCIT presentation and the information therein shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference
in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a
filing.

http://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=11152890&type=HTML&symbol=MCET&companyName=Multicell+Techs+Inc&formType=8-K&dateFiled=2016-09-26